Keyword: Merck


German Merck Licenses Fusion Protein to PDS

10.01.2023 -

Germany‘s Merck has granted an exclusive license for the tumor-targeting IL-12 fusion protein currently known as M9241 to PDS Biotechnology Corporation, a US-based...


Germany’s Merck Buys Erbi Biosystems

12.12.2022 -

Germany’s Merck has acquired Erbi Biosystems, a developer of the 2 ml micro-bioreactor platform technology known as the Breez. Financial terms were not disclosed. The...


Germany’s Merck Realigns Drug R&D Strategy

24.11.2022 -

In a move to advance productivity, the healthcare division of Germany’s Merck is realigning its drug discovery and launch strategy. Global healthcare research chief Danny...


Germany’s Merck Invests in US Biosafety Test Capacity

18.11.2022 -

Germany’s Merck is investing over €290 million in US biosafety testing capacity at Rockville, Maryland, to “significantly increase” its ability to meet double-digit...


White Paper: Safety in the Laboratory

18.11.2022 -

Anyone working in a laboratory must familiarize themselves with rules and precautions for working safely. In day-to-day laboratory work, it is often not easy to keep...


Pharma CEOs Take Action on Climate Change

08.11.2022 -

The CEOs of seven multinational pharmaceutical companies have announced that they are taking joint action to achieve near-term emissions reduction targets and accelerate...


Merck & Co and Moderna Proceed with Cancer Vaccine

18.10.2022 -

US drugmaker Merck & Co is going ahead with plans to develop a therapeutic cancer vaccine called mRNA-4157 together with Covid vaccine maker Moderna. This fulfills an...


Millipore CTDMO Services Opens Facility in France

06.10.2022 -

Millipore CTDMO Services, part of the Life Science arm of Germany’s Merck, has opened a commercial facility in France.